Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.34 per Ordinary share on 8 October 2009 through the Company's ShareReward Plan ("the Plan") which the under-mentioned persons entered on 5 October 2001:
Mr A P Witty | Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr J S Heslop | Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr S M Bicknell | Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr E J Gray | Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr S A Hussain | Acquisition of 7 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr D Learmouth | Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan |
Dr D Pulman | Acquisition of 9 Ordinary shares under the Dividend Reinvestment element of the Plan |
Mr D S Redfern | Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan |
Ms C Thomas | Acquisition of 23 Ordinary shares under the Dividend Reinvestment element of the Plan |
The Company and the above-mentioned persons were advised of this information on 12 October 2009.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
12 October 2009
RNS news service provided by Hemscott Group Limited.